135 related articles for article (PubMed ID: 6693048)
1. Interobserver variability in the interpretation of epithelial ovarian cancer.
Hernandez E; Bhagavan BS; Parmley TH; Rosenshein NB
Gynecol Oncol; 1984 Jan; 17(1):117-23. PubMed ID: 6693048
[TBL] [Abstract][Full Text] [Related]
2. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Hauptmann S; Friedrich K; Redline R; Avril S
Virchows Arch; 2017 Feb; 470(2):125-142. PubMed ID: 28025670
[TBL] [Abstract][Full Text] [Related]
3. Observer variation in histologic classification of malignant and borderline ovarian tumors.
Stalsberg H; Abeler V; Blom GP; Bostad L; Skarland E; Westgaard G
Hum Pathol; 1988 Sep; 19(9):1030-5. PubMed ID: 3417288
[TBL] [Abstract][Full Text] [Related]
4. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
Malpica A; Deavers MT; Tornos C; Kurman RJ; Soslow R; Seidman JD; Munsell MF; Gaertner E; Frishberg D; Silva EG
Am J Surg Pathol; 2007 Aug; 31(8):1168-74. PubMed ID: 17667538
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
[TBL] [Abstract][Full Text] [Related]
6. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
[TBL] [Abstract][Full Text] [Related]
7. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
[TBL] [Abstract][Full Text] [Related]
8. Observer disagreement in histological classification of ovarian tumors in Japan.
Sakamoto A; Sasaki H; Furusato M; Suzuki M; Hirai Y; Tsugane S; Fukushima M; Terashima Y
Gynecol Oncol; 1994 Jul; 54(1):54-8. PubMed ID: 8020839
[TBL] [Abstract][Full Text] [Related]
9. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
10. Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing.
Baak JP; Langley FA; Talerman A; Delemarre JF
Anal Quant Cytol Histol; 1986 Dec; 8(4):354-7. PubMed ID: 3814303
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
12. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.
Shimizu Y; Kamoi S; Amada S; Akiyama F; Silverberg SG
Cancer; 1998 Mar; 82(5):893-901. PubMed ID: 9486579
[TBL] [Abstract][Full Text] [Related]
13. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
[TBL] [Abstract][Full Text] [Related]
14. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features.
Fadare O; Parkash V; Dupont WD; Acs G; Atkins KA; Irving JA; Pirog EC; Quade BJ; Quddus MR; Rabban JT; Vang R; Hecht JL
Am J Surg Pathol; 2012 Aug; 36(8):1107-18. PubMed ID: 22790851
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study.
Köbel M; Kalloger SE; Baker PM; Ewanowich CA; Arseneau J; Zherebitskiy V; Abdulkarim S; Leung S; Duggan MA; Fontaine D; Parker R; Huntsman DG; Gilks CB
Am J Surg Pathol; 2010 Jul; 34(7):984-93. PubMed ID: 20505499
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implications.
Lund B; Thomsen HK; Olsen J
APMIS; 1991 Apr; 99(4):353-8. PubMed ID: 2036219
[TBL] [Abstract][Full Text] [Related]
17. Confidence of expert ultrasound operators in making a diagnosis of adnexal tumor: effect on diagnostic accuracy and interobserver agreement.
Yazbek J; Ameye L; Testa AC; Valentin L; Timmerman D; Holland TK; Van Holsbeke C; Jurkovic D
Ultrasound Obstet Gynecol; 2010 Jan; 35(1):89-93. PubMed ID: 19757401
[TBL] [Abstract][Full Text] [Related]
18. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of borderline and malignant mucinous ovarian tumours.
Baak JP; Blanco AA; Kurver PH; Langley FA; Boon ME; Lindeman J; Overdiep SH; Nieuwlaat A; Brekelmans E
Histopathology; 1981 Jul; 5(4):353-60. PubMed ID: 7275019
[TBL] [Abstract][Full Text] [Related]
20. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]